The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Expert review
Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base
EuroIntervention 2012;7:1103-1110 publish online ahead of print September 2011. DOI: 10.4244/EIJV7I9A175
Annette Maznyczka1*, BSc, MBChB; Aung Myat2, BSc, MBBS, MRCP; Anthony Gershlick1, BSc, MBBS, FRCP
1. Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom; 2. The Rayne Institute, St Thomas’ Hospital, King’s College London, London, United Kingdom
Aims: Metformin is widely prescribed for the treatment of type 2 diabetes mellitus and is associated with a reduction in diabetes-induced cardiovascular morbidi
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
metforminlactic acidosiscoronary angiographyguidelines
Read next article
How should I treat an iatrogenic aortic dissection as a complication of complex PCI?